Evaluating general movements to diagnose neurological disorders in children
An Observational Cohort Study of Prognostic Value of Generalized Movements in the Diagnosis of Neurological Diseases in Children
This study is testing if watching how babies move can help doctors spot neurological disorders early in children aged 0 to 5 months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 1 Day to 2 Years |
| Sex | All |
| Sponsor | West Kazakhstan Medical University Academic / other |
| Locations | 1 site (Aktobe) |
| Trial ID | NCT05262088 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the evolution of general movements in children to establish criteria for the early diagnosis of neurological disorders, potentially reducing early neurological disabilities. It will involve a longitudinal analysis of a cohort of children aged 0 to 5 months in the Aktobe region, focusing on the relationship between their motor repertoire and various demographic and prenatal factors. The study will include approximately 1800 children, with evaluations conducted by trained specialists using video recordings of the children's movements.
Who should consider this trial
Good fit: Ideal candidates for this study are full-term newborns born in the city of Aktobe whose parents consent to participate.
Not a fit: Patients who may not benefit from this study include premature infants and those with suspected chromosomal or metabolic diseases.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and intervention for neurological disorders in children, improving long-term outcomes.
How similar studies have performed: While this approach is based on existing knowledge of general movements, the specific application in this population cohort is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all full-term newborn children born in the city of Aktobe in the period from * both male and female children * patients whose parents have signed an informed consent to data collection * patients, as long as parents are able to comply with the requirements of the study protocol. Exclusion Criteria: * premature babies * children with suspected chromosomal and metabolic diseases * children of parents who have not signed the informed consent. * children with fatal outcome are excluded in dynamics
Where this trial is running
Aktobe
- Zhanna Zhussupova — Aktobe, Kazakhstan (Recruiting)
Study contacts
- Principal investigator: Dinmuhammed Ayaganov — West Kazakhstan Medical University
- Study coordinator: Zhanna Zhussupova
- Email: tleuzhanna@mail.ru
- Phone: +77017910795
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.